Clinical
Trials
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
At BeiGene, we’re committed to bringing patients worldwide potential treatment options. We are currently recruiting clinical trials across areas including lymphoma, liver cancers, lung cancers, gastric cancers, breast cancers, and more.
-
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
Condition:
B-cell Malignancies
Molecule:Zanubrutinib
-
A Study of BGB-11417 in Participants With Myeloid Malignancies
Condition:
Acute Myeloid Leukemia
Molecule:BGB-11417
-
AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent o…
Condition:
Cervical Cancer
Molecule:Tislelizumab + Ociperlimab
-
Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab
Condition:
Breast Cancer, Gastric Cancer
Molecule:Tislelizumab + ZW25
-
Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Participant With ESCC
Condition:
Esophageal Squamous Cell Carcinoma (ESCC)
Molecule:Tislelizumab
-
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
Condition:
Urothelial Carcinoma
Molecule:Tislelizumab
-
Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Condition:
Lung Cancer
Molecule:Tislelizumab
-
Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies
Condition:
Mature B-cell Malignancies
Molecule:Zanubrutinib
-
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Condition:
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Molecule:Tislelizumab
-
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Condition:
Locally Advanced or Metastatic Solid Tumors
Molecule:Pamiparib
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.
This list includes trials with the following recruitment statuses: recruiting, enrolling by invitation, study start-up, not yet recruiting, and active/not recruiting.